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Abstract 
In non-viral gene delivery, the variance of transgenic expression stems from the low 
number of plasmids successfully transferred. Here, we experimentally determine 
Lipofectamine- and PEI-mediated exogenous gene expression distributions from single cell 
time-lapse analysis. Broad Poisson-like distributions of steady state expression are 
observed for both transfection agents, when used with synchronized cell lines. At the same 
time, co-transfection analysis with YFP- and CFP-coding plasmids shows that multiple 
plasmids are simultaneously expressed, suggesting that plasmids are delivered in correlated 
units (complexes). We present a mathematical model of transfection, where a stochastic, 
two-step process is assumed, with the first being the low-probability entry step of 
complexes into the nucleus, followed by the subsequent release and activation of a small 
number of plasmids from a delivered complex. This conceptually simple model 
consistently predicts the observed fraction of transfected cells, the cotransfection ratio and 
the expression level distribution. It yields the number of efficient plasmids per complex 
and elucidates the origin of the associated noise, consequently providing a platform for 
evaluating and improving non-viral vectors.  
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Introduction 
Non-viral gene delivery systems have evolved over the last decade into widely-used 
vectors for exogenous DNA delivery to eukaryotic cells. Synthetic cationic lipids and 
polymers, in particular, are used in molecular biology for transgene expression, and are 
being further refined for use in DNA-based therapies (Ferber 2001; Roth and Sundaram 
2004) (Patil et al. 2005). Despite considerable progress in the efficiency and 
characterization of vectors, important aspects of the delivery pathway and transfer kinetics 
remain poorly understood, including how artificial vectors are taken up, transported to the 
nucleus, and how these factors collectively influence the expression characteristics of a cell 
population. Current understanding from intracellular studies of transgene delivery includes 
the following steps: DNA-vector complex uptake via the endosomal pathway, followed by 
endosomal escape and cytoplasmic transport, nuclear entry, vector unpacking and 
transcription initiation (Roth and Sundaram 2004) (de Bruin et al. 2007; Kircheis et al. 
2001; Lechardeur et al. 2005; Safinya 2001; Suh et al. 2003). These processes are 
accompanied by a huge loss of material and temporal delays. It is therefore not surprising 
that transfected cells in a culture respond very heterogeneously over time, notably in terms 
of the expression onset time (ton) and the maximum expression levels attained. It is 
generally accepted that the expression behavior of a single transfected cell is stochastic, yet 
cell culture averaged expression levels are reliable indicators of gene transfer efficiency.  
Flow cytometry is commonly used to measure fluorescence distributions over a population 
at a rate of up to 10000 cells per second (Longo and Hasty 2006). High- content single cell 
assays, in contrast, are particularly suitable for investigating the dynamics and 
heterogeneity of clonal cell populations, since individual cells can be followed with a high 
temporal resolution. In addition, quantitative image analysis has been successfully 
improved to reliably convert fluorescence intensities into copies of molecules, hence 
paving the path to follow ‘gene expression by numbers’ (Rosenfeld et al. 2005). 
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In this paper, we analyze gene expression following non-viral gene delivery, with focus on 
the variance of expression levels. The expression of genes exhibits all-or-nothing 
characteristics (Hume 2000) and additional stochasticity exists in transcriptional regulation 
(McAdams and Arkin 1999) (Rao et al. 2002). Elowitz et al. have analyzed noise in 
bacterial gene expression and elucidated the distinction between extrinsic and intrinsic 
noise, i.e. the contribution of fluctuations in cellular components and inherent stochasticity 
of the biochemical processes during gene expression (Elowitz et al. 2002). The extrinsic 
variance of gene expression within a clonal population of eukaryotic cells has been 
investigated in the light of stochastic theories(McAdams and Arkin 1997; Volfson et al. 
2006) (Blake et al. 2003) (Raser and O'Shea 2004). It was only recently that attempts were 
made to generate models for transgene expression following non-viral gene delivery 
(Varga et al. 2000) (Varga et al. 2001) (Dinh et al. 2007) (Zhou et al. 2007). 
Computational modeling might greatly enhance our understanding of gene transfer and aid 
in elucidating the nature of the underlying transport barriers.  Many of the issues regarding 
cell entry and intracellular transport are shared with attempts to model viral infection 
(Varga et al. 2005) (Douglas 2008).  
 In this article, we used quantitative single cell time-lapse microscopy combined with 
mathematical modeling to analyze the variability in transgene expression (Fig. 1). From the 
synthetic delivery agents currently being evaluated for therapeutic use, we chose 
polyethyleneimine (PEI) (Boussif et al. 1995) and the commercial Lipofectamine 2000, as 
cationic polymer and lipid model systems, respectively. Both synthetic vectors are able to 
condense plasmid DNA into DNA-nano particles, denoted as cationic lipid- (cationic polymer-) 
DNA complexes or just "complexes". Distributions of the expression onset times and 
expression steady state levels were evaluated for both vectors.  
Data are well described by a stochastic delivery model, which is based on the assumption that 
in a decisive step, only a small number of complexes enter the nucleus through a stochastic 
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process. Out of these complexes, only a fraction of the plasmid load is expressed (Fig. 1). The 
theoretical model is further corroborated by a cotransfection analysis, i.e. the case of the 
simultaneous transfection using two distinguishable plasmids encoding for CFP and YFP. It is 
shown that this model consistently describes the fraction of transfected cells and the observed 
expression level distribution. As a consequence the effective size of a stochastically delivered 
unit of plasmids (complex) can be determined. 
 
 
Materials and Methods 
Cell culture. A human bronchial epithelial cell line (BEAS-2B, ATCC) was grown in 
Earle’s MEM supplemented with 10% FBS at 37°C in a humidified atmosphere, 5% CO2 
level. Transfection was performed on both non-synchronized and synchronized cultures. A 
thymidine kinase double-block was performed to synchronize cells.  
 
Transfection. BEAS-2B cells were grown to 80% confluence from an initial seeding 
density of 1 x 105 cells/well in six-well plates 24 hours before transfection. Cells were 
washed and the medium is replaced with 1 ml OptiMEM/well immediately before 
transfection. Optimized transfection procedures were performed using either 2% v/v 
LipofectamineTM2000/OptiMEM or PEI (N/P=8)/HBS; 1 µg of pEGFP-N1 or pd2EGFP-
N1, is used for transfecting each batch of cells. The transfection medium was prepared 
either by adding the Lipofectamine or the PEI solution to the plasmid solution. After the 
transfection media were allowed to stand for 20 minutes the cells were incubated with 200 
µl/well Lipofectamine or PEI transfection medium for 3 hours at 37°C, 5% CO2 level. 
After 3 hours of incubation the medium was removed, and cells were washed with PBS. 
Cells were reincubated with Leibovitz’s L-15 Medium with 10% FBS prior to EGFP 
expression monitoring. 
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Cotransfection. Cotransfection was performed with two kinds of preparations containing 
the same molar amount per plasmid. For one preparation, ECFP/Lipofectamine, 
EYFP/Lipofectamine, ECFP/PEI and EYFP/PEI were complexed separately. For the other, 
a mixture of ECFP and EYFP hetero-complexes were complexed with Lipofectamine or 
PEI. Transfection using either the hetero-complexes (pre-mixed) or a mixture of homo-
complexes (post-mixed) was performed as previously described. Cells were reincubated in 
growth medium and CFP and YFP expression was monitored by fluorescence microscopy 
after 24 hours. 
 
Data acquisition and quantitative image analysis. Images were taken at 10× 
magnification, with a constant exposure time of 1s, at 10 minute-intervals for at least 30 
hours post-transfection. Fluorescence images are consolidated into single image sequence 
files. Negative control images were taken to assess lamp threshold values and 
autofluorescence, and were subtracted from corresponding image sequence files to 
eliminate autofluorescence effects. To capture cell fluorescence over the entire sequence, 
regions of interest (ROIs) were manually defined around each cell (Fig. 2). Changes in 
total gray measurements in individual ROIs were determined for each time point. 
 
 
Results 
 
Time lapse microscopy and single cell EGFP expression  
A cell line of lung epithelium cells was transfected with a plasmid encoding for the green 
fluorescent protein (EGFP). Transfection protocols for PEI- and Lipofectamine-mediated 
delivery followed standard procedures and are described in detail in the supplementary 
online information. We denote the time of the gene vector administration to the cell culture 
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as t = 0h. Transfection medium was removed and cell growth medium added at t = 3h. 
Single-cell EGFP expression was monitored by automatically taking sequences of 
fluorescence micrographs from 25 view fields at 10-minute intervals. Fig. 2a shows a 
representative sequence from a Lipofectamine transfection experiment, with the initial 
bright field image, as well as the EGFP fluorescence at t = 4, 8 and 12 hours post-
transfection. These images demonstrate heterogeneity in both the expression onset times 
and levels of exogenous gene expression. It is observed that the number of fluorescent cells 
increases with time; at the late stage (~30h), the ratio of fluorescent to non-fluorescent cells 
is about 23% and 30% for PEI- and Lipofectamine-mediated transfection, respectively. A 
total of 500-1500 cells were monitored in parallel within one time-lapse experiment. 
Individual time courses of the total fluorescence per cell were evaluated by image 
processing from data stacks as shown in Fig. 2b and described in the supplementary online 
information. Fig. 2c shows a series of representative time traces from one transfection 
experiment, illustrating the significant variance in both the expression onset time and EGFP 
expression level. The typical sigmoidal shape of the time courses is well described by the 
phenomenological function,  
( )[ ]rise21max )(tanh12)( ttt
ItI −+= ,   [1] 
which allows the determination of the maximal fluorescence plateau value (Imax) the time of 
half-maximum (t1/2) and the characteristic rise time,  trise. The fluorescence intensities were 
converted into molecular units using EGFP standard beads for calibration (see 
supplementary online information). In the remainder of the text we will give the 
fluorescence intensity Imax in units of EGFP numbers G. Eq. 1 proved to be robust for 
automated data analysis, facilitating the accumulation of statistics for a large number of 
individual cells. In order to determine the time points of expression onset, ton , we use t1/2 - 
trise as an approximation due to the lack of a well-defined point of onset as shown in Fig. 2d. 
Since the timing of gene expression is expected to be dependent on the cell cycle, we 
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investigated the distribution of ton for synchronized and non-synchronized cells. To this end, 
cells were arrested at the G1/S-Phase transition using a thymidine kinase double-block 
(Merrill 1998).  
 
Distribution of expression onset times 
Fig. 3 summarizes the measured distribution functions of ton and Imax for GFP expression 
after transfection of non-synchronized and synchronized cultures with PEI- and 
Lipofectamine-based complexes respectively. Expression onset times range from 5 and 25 
hours for both PEI- and Lipofectamine, indicating the existence of a time window during 
which plasmids are successfully transcribed in the nucleus. The distribution for 
Lipofectamine clearly peaks at an earlier time (~8h) compared to PEI, (~16h). On cell cycle 
synchronization, the distribution of onset times sharpen and become peaked at about t = 15h 
for both PEI and Lipofectamine. Bright field images reveal that most synchronized cells 
divide 12 hours after transfection. This is consistent with the fact that transfection was 
carried out in mid-S-phase, three hours after release from the thymidine kinase double-
block. This shows that plasmid activation occurs about three hours after the M-phase. 
Furthermore, since cell cycle synchronization suppresses expression at earlier times, there is 
evidence that the delivery process depends on the cell cycle dependent breakdown of the 
nuclear membrane. This is consistent with previous studies claiming that mitosis enhances 
transgene nuclear translocation in cationic lipid gene delivery (Tseng et al. 1999) (Mortimer 
et al. 1999) (Brunner et al. 2000). We also find that synchronization leads to a 2-fold higher 
steady state expression for PEI- (from 2.6⋅106 to 4.3⋅106 average EGFP molecules per cell) 
and Lipofectamine- (from 2.9⋅106 to 5.1⋅106 average EGFP molecules per cell) mediated 
transfection, consistent with earlier observations on ensemble averaged data (Brunner et al. 
2000). 
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Modeling steady state gene expression  
In order to analyze the distribution of expression steady states, we introduce a 
mathematical model that describes EGFP expression after transfer and nuclear translocation 
of complexes containing exogenous EGFP plasmids. Stochasticity due to nuclear 
translocation of the plasmid complexes and the intra-nuclear activation will give rise to a 
probability distribution P(X) for X successfully expressed plasmids (see Fig. 4a). In the first 
stage of analysis, we describe the expression of EGFP from a single activated plasmid in a 
linear deterministic model and neglect any cell-cell variability. Based on the biochemical 
reactions shown in Fig. 4b we denote the ensuing rate equations: 
€ 
R
•
= sAX −δRR    [2] 
€ 
U
•
= spR − kM + δU( )U   [3] 
€ 
G
•
= kMU −δGG    [4] 
Here, R denotes the number of RNA molecules, U the number of unfolded polypeptide 
chains, and G the number of folded EGFP proteins. sA, sP and kM, denote the rate constants 
for transcription, translation and EGFP maturation, δR, δU, and δG denote the degradation 
constants of each product, respectively. The degradation rates of folded (δG) and unfolded 
protein (δU) are assumed to be equal, since the same proteases are involved (Leveau and 
Lindow 2001). A plasmid degradation term was omitted, since its occurrence is predicted to 
be negligible within the time frame considered (Subramanian and Srienc 1996). Literature 
values for the individual kinetic rates are summarized in Table I. Equations 2-4 can be 
solved analytically. For the steady state value, a linear relation  
( )
X
k
ssktGI
GMRG
APM ⋅
+
=∞→=
δδδ
)(max   [5] 
between the expression level Imax = [GFP] and the number of expressed plasmids X = 
[plasmids] is obtained: 
€ 
GFP[ ] = kexp ⋅ plasmids[ ] .    [6] 
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Here, kexp denotes an effective expression factor, corresponding to the number of proteins 
expressed per transcribed plasmid in the steady state. With the values given in Table I, we 
find kexp ≈ 4·106 molecules/plasmid, which compared to the experimental number of 
molecules (1-15·106), results in the remarkable finding that the number of plasmids X is of 
order one. This implies that most of the variance in expression level originates from 
stochastic variations in the small number of plasmids, such that the distribution of GFP 
expression is determined by the distribution of successfully delivered plasmids, P(G )~ 
P(X). 
 To further substantiate this conclusion, we designed an experiment where the 
expression factor kexp is deliberately modified through the use of destabilized EGFP. It has a 
14-fold higher degradation rate (δdesG) due to an additional amino acid sequence (PEST), 
which makes it more susceptible to proteolysis (Kain 1999). Figs. 3e and 3f display the shift 
in the steady state distribution of Imax, shown in a logarithmic scale. As predicted above, the 
shape of the distribution function is almost unchanged for both PEI- and Lipofectamine-
mediated transfection.  In addition, the peak positions shifted by a factor 12.5, which is 
close to the value 14.3 predicted from Eq. 5.  
 
Modeling transfection noise 
Unlike in chromosomal DNA, which contains a fixed number of genes, the transfection 
experiments discussed here result in the delivery of a variable number of genes per vector. 
We model gene delivery as a two-step stochastic process as shown in Fig. 4a. As we will 
argue in the following, a two-step model is the simplest model that is in accordance with 
the experimental data. The model consists of (i) the nuclear translocation with probability 
µ of complexes containing an average of m plasmids and (ii) intra-nuclear activation of 
plasmids, with probability q. Whereat the probability q subsumes all phenomena 
promoting or interfering with transcription such as DNA methylation or complexation. We 
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assume that the first process, the delivery of complexes to the nucleus, is rare and 
statistically independent, yielding a Poisson distribution for the number of delivered 
complexes C: 
€ 
P(C) = µ
C
C! e
−µ     [7] 
characterized by its mean value µ. Secondly, the independent activation of a plasmid in the 
nucleus is described by a Bernoulli process with success probability q. The concatenation 
of both processes results in an expression for P(X) which retains the characteristics of a 
Poissonian. Mathematical details of its derivation can be found in the supplementary data. 
Fig. 5 shows the calculated distribution of activated plasmids, P(X) (red bars), to the 
measured experimental protein distribution, Pexp(G) (green bars). In addition a theoretical 
protein distribution is shown as black lines. Ptheo(G) is obtained from P(X) by additionally 
accounting for noise in gene expression, where we have used a relative magnitude of 0.3 
for post-transfectional noise from the literature (see supplementary data). Note that the x-
axis of the distributions P(G) are rescaled by the factor kexp according to Eq.6. The 
agreement between experiment and model is remarkable considering that there is only one 
free parameter in the fit. This is due to the fact that two additional experimental constraints 
have to be met. These are the measured fraction of transfected cells, TR, defined as the 
percentage of cells expressing one or more plasmids, and the average number of GFP 
molecules per cell, <G>, determined by calibration. The parameters µ and m⋅q are fixed by 
these constraints. The remaining unknown is the expression factor, kexp, which is 
determined by the fit shown in Fig. 5. We obtain kexp ≈ 1⋅106, meff ≈ 3, and µ ≈ 0.3-0.5.  
The red curve in Fig. 5 represents the distribution of successfully expressed plasmids. This 
distribution, which is directly related to the number of expressed GFP protein though Eq. 
6, has a well defined mean value given by: 
€ 
plasmids[ ] = µ ⋅m ⋅ q   [8] 
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The transfection ratio, TR, is related to this mean plasmid number. It depends on the 
average number of complexes delivered µ and the effective probability  that from any 
given complex at least one plasmid is transcribed (we present a complete derivation of 
these quantities in the supplementary data).  
  [9] 
For the data shown in Fig. 6, TR is of order 20%. 
 
Cotransfection and correlated delivery 
One important ingredient of our model is the delivery of DNA in units or complexes and 
the subsequent correlated coexpression of multiple plasmid copies. This assumption is 
closely related to the question of whether DNA-complexes fully dissociate before nuclear 
entry or complexes enter the nucleus as a whole. To elucidate this issue, we studied 
cotransfection of two distinguishable plasmids (CFP and YFP) and analyzed the outcome 
of transfection using pre-mixed and post–mixed complexes. Pre-mixed complexes contain 
both CFP- and YFP-plasmids in a single complex, whereas post-mixed complexes contain 
either CFP- or YFP-plasmids (for clarity see Figs. 6a and 6b). The steady-state CFP/YFP 
expression was analyzed at 24h post-transfection. We define the cotransfection ratio, r, as 
the number of cells expressing both CFP and YFP divided by the number of cells 
expressing either CFP or YFP. We find that the cotransfection ratio increases from 12.9% 
for post-mixed complexes to 21.9% for premixed complexes. The significant difference 
could not be explained, if complexes were completely dissolved in the cytosol and delivery 
of plasmids was independent from the complexes. The two-step delivery model, however, 
naturally explains the discrepancy between pre-mixed and post-mixed complexes. Based 
on our model an analytical expression for the cotransfection ratio can be derived (see 
supplementary data) which predicts correctly the measured cotransfection ratios, if the 
same parameters are used as determined from the EGFP distribution function. 
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Discussion  
We have measured the distribution of expression onset times and steady-state 
expression levels derived from single cell fluorescence time courses. Distributions of onset 
times of PEI and Lipofectamine collapse on a single curve for synchronized cell cultures, 
suggesting a universal cell cycle-dependent gene delivery mechanism. Synchronized cells 
exhibit a broad Poissonian distribution in expression levels and cotransfection experiments 
reveal correlations in the delivery probability for plasmids contained in one complex.  
Invoking Occam’s razor, we analyzed the findings in terms of an idealized minimalist 
model of gene transfection, which describes gene delivery as a two-step stochastic process. 
Yet our model proves to have considerable predictive power by relating measurable 
quantities such as the overall transfection efficiency, the cotransfection probability and the 
shape of the gene expression distribution with each other. Thus, the model allows to derive 
the expression factor, the number of activated plasmids per complex and the average 
number of delivered complexes from the measured single cell transfection statistics. The 
model also elucidates the origin of expression variance, separating the noise due to small 
number fluctuations of complexes, which is inherent to the delivery process and extrinsic 
sources of noise due to cell-cell variability. 
In our gene expression model we refer to complexes as units of coherently delivered 
plasmids. Those indirectly infered complexes are consistent with but not necessarily 
identical to the complexes described in many physico-chemical studies of PEI and 
lipofectamine mediated transfection. Cationic-lipid complexes are known to form multi-
lamellar aggregates that contain a large number of plasmids (Zabner et al. 1995) (Rädler et 
al. 1997) (Lasic et al. 1997). Following endocytotic uptake and release, the complexes 
slowly dissociate in a stepwise, unwrapping mechanism (Lin et al. 2003) (Kamiya et al. 
2002). PEI complexes are torroids or rods with a typical hydrodynamic radius of 100nm 
(Boussif et al. 1995) (DeRouchey et al. 2005), they have been seen to be actively 
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transported inside cells (de Bruin et al. 2007) and to accumulate in the periphery of the 
nucleus (Suh et al. 2003). Both scenarios describe a situation where numerous small 
complexes have equal chances of entering the nucleus during the course of mitosis, which 
is consistent with our model assumptions. Microscopy studies have argued favorably for 
complexes being at least not fully dissolved at the final delivery stage (Lin et al. 2003) 
(Tseng et al. 1999). However, single nuclear entry events have not been documented 
explicitly. The probability of transgene expression in the nucleus again depends on the 
nature of the transfection agent. Pollard et al reported that cationic lipids but not PEI 
prevent gene expression when complexes are directly injected in the nucleus(Pollard et al. 
1998). Such findings can only be consolidated with our model, if the delivered complexes 
transform during the course of the delivery, rather than being the same physical complexes 
as originally prepared under in vitro conditions. Within the context of our model we 
restrict ourselves to a narrowed meaning of “complexes” as units of plasmids that are co-
delivered. In this framework, we determine the average number of successfully delivered 
complexes and the effective number of activated plasmids per complex from the analysis 
of single cell statistics. It will be interesting to corroborate the physical fate and the 
expression outcome of single complexes by high resolution studies in single cells (de Bruin 
et al. 2007).  
The method to use transfection assays based on automated high-throughput 
microscopy combined with image processing might evolve into a routine tool for the 
assessment of transfection efficiency. In contrast to ensemble averaged fluorescence or 
luminescence data, single cell assays yield precise distribution functions and single cell 
expression dynamics, which allow a more detailed comparison to theoretical models. As 
shown here, the analysis of steady state expression levels provides access to the probability 
of successful plasmid delivery (P(X)) and yields an absolute number for the expression 
factor (kexp). In forthcoming work we will discuss in more detail the distribution of 
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expression onset times and the expression dynamics. We expect that our particular 
mathematical model can be adapted to a wider class of transfection agents and different 
types of cells. Their distinct transfection ratios, rate constants and numbers of effective 
complexes will become even more meaningful in the context of comparative theoretical 
modeling. A combined experimental and modeling approach will hence help to identify 
rate-limiting barriers to gene transfer and will result in improved data comparability, 
making it a versatile tool in the continuous evaluation and improvement of existing 
synthetic vectors.  
 
 
Additional information regarding the transfection assays, image processing, data analysis and 
the mathematical model are available under supplementary data. 
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Table Legends 
 
Table I. Literature values for the kinetic rates of the linear gene expression model 
 
 
Figure Legends 
 
Figure 1. Experimental setup for single cell transfection experiments (upper part) and key 
elements of the theoretical model (lower part). EGFP-encoding plasmids and cationic 
agents form complexes, which are administered to eukaryotic cell cultures. Automated 
single cell microscopy yields statistics on phenotypic expression of EGFP. For the delivery 
of plasmids to the nucleus, stochastic effects are important, while the following expression 
of fluorescent proteins can be described in a deterministic fashion. 
 
Figure 2. Acquisition of single cell time series. (a) Microscopy viewfields from a 
Lipofectamine transfection experiment. The first frame is a bright field (BF) control image. 
Fluorescence image sequences are taken automatically at ten minute intervals for at least 30 
hours. (b) Definition of regions of interest (ROIs), total gray value measurement and 
conversion to the number of EGFP molecules. (c) Representative time-courses of EGFP 
expression in individual cells following PEI-transfection. The population average (red) is 
plotted to demonstrate its linear increase in contrast to the sigmoidal shape of the individual 
traces. (d) Characteristic parameters of expression are obtained by fitting the heuristic 
function 1 (red) to the recorded fluorescence time course (black). The time of expression 
onset, ton, is calculated from the time of half-maximal expression t1/2 and the slope at that 
point. 
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Figure 3. EGFP expression statistics for PEI- and Lipofectamine-mediated transfection. 
Distributions of expression onset times ton (a,b) and maximal expression values Imax (c,d), 
for PEI- (red) and Lipofectamine- (dashed black) mediated transfection depict strong 
variability within the cell cultures. The total number of expressing cells was 23% out of 560 
for PEI and 30% out of 502 in the case of Lipofectamine. (b,d) thymidine kinase - 
synchronized cultures with 40% out of 1981 and 30% out of 1797 cells expressing EGFP 
for PEI and Lipofectamine, respectively. For synchronized cells, expression onset time 
distributions coincide for Lipofectamine and PEI, indicating that transfection is more likely 
to happen in specific phases of the cell cycle. Distributions for Imax (given in units of EGFP 
molecules) cannot be explained by post-transfectional sources of fluctuations alone. (e, f) 
Effect of the altered expression rates on the distribution of maximal expression levels Imax. 
Distributions for d2EGFP (gray) and EGFP (red) transfected with Lipofectamine (e) or PEI 
(f) are shown. d2EGFP, which has a higher degradation rate, exhibits a systematic shift of 
the Imax distribution compared to EGFP, independent of the vector used. Besides this shift, a 
change in the number of proteins per active plasmid, kexp, preserves the shape of the 
distribution. This suggests that the shape is determined during plasmid delivery prior to 
expression. 
 
Figure 4. Theoretical model for transfection and gene expression. (a) Our model of 
plasmid delivery consists of several stochastic components. The number of complexes C 
delivered per cell is Poisson-distributed, with mean µ. Each complex carries a random 
number of plasmids, described by a Poisson distribution with mean m. Finally, each 
plasmid has an activation probability q, resulting in a Binomial distribution of active 
plasmids X out of the total number of delivered plasmids. With this approach, the overall 
distribution, P(X), of actively expressing plasmids can be derived. (b) Deterministic model 
of EGFP expression including transcription (sA), translation (sP) and protein maturation 
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(kM). mRNA (R), unfolded proteins (U) and GFP (G) are degraded with rates δR, δU and δG, 
respectively. Solving the corresponding rate equations, the steady state distribution of 
fluorescent proteins, P(G), can be related to that of active plasmids, P(X). 
 
Figure 5. Comparison of single-cell data with the theoretical model. The theoretical EGFP 
distribution (black) is intimately connected with the underlying distribution of expressing 
plasmids (red). To facilitate comparison, the protein distribution has been scaled down by 
the average number of proteins per active plasmid in steady state, kexp. (a,b) For 
synchronized cultures the measured protein distribution (green) is fitted very well by our 
theoretical model (black). The fit for PEI transfection (a) yields an average number of 
delivered complexes, µ = 0.53, and an average number of activated plasmids per complex, 
meff = 3.2. In the case of Lipofectamine (b), we find µ = 0.37 and meff = 3.2.  
 
Figure 6. Correlated delivery in CFP/YFP cotransfection with post-mixed (uni-colored) 
complexes (left) and pre-mixed (dual-colored) complexes (right). (a,b) Post-mixed (uni-
colored) and pre-mixed (dual-colored) complexes carry different plasmid content, but take 
the same pathway to the nucleus. (c,d) Superposition of CFP and YFP fluorescence after 
transfection reveals a qualitatively different expression pattern for the two distinct 
experimental protocols. Cyan fluorescence is slightly displaced to permit identification of 
cotransfected cells. All micrographs are artificially colored.  
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Probability distribution of active plasmids per cell 
The probability P(X) of finding X plasmids expressed in a given cell can be computed from 
a convolution of all underlying stochastic processes that occur prior to transcription 
initiation. Supposing X plasmids have been activated, then n ≥ X plasmids first had to be 
delivered to the nucleus, with a probability q for each plasmid to be expressed. This results 
in a binomial distribution with sample size n and parameter q: 
 .       [S1] 
Two relevant stochastic processes determine the number of delivered plasmids n, namely, 
the number of complexes C that arrive in the nucleus, and the number of plasmids in a 
given complex. We assume Poisson distributions for both, with means µ and m, 
respectively. Summing over all possibilities, we get the distribution 
       [S2] 
for n. Here we have used that the convolution of C Poisson distributions, each with mean 
m, is again a Poissonian with mean C·m. 
Considering the previous two equations the overall probability of having X active plasmids 
is 
.  [S3] 
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By interchanging the order of summation, shifting summation indices and using the 
normalization condition of the Poisson distribution, this can be rewritten as 
.       [S4] 
Summing from X = 1 to infinity yields the transfection probability 
      [S5] 
which corresponds to Eq. 9 of the main text. 
 
Cotransfection Probabilities 
We are interested in the number of cells that are either monochromatic, dichromatic or not 
fluorescent at all. To compute the probabilities for each, a sum over all possible plasmid 
numbers X has to be evaluated, with each term in the sum weighted with the probability of 
activation of zero, one, or two species, depending on the case being considered. If there are 
i plasmids of one color in the nucleus, the probability that none are activated is (1-q)i, while 
the probability that at least one is activated is 1-(1-q)i 
The two cotransfection experiment setups were explained in the Material and Methods 
section. For uni-colored complexes (post-mixing), the total number of complexes can be 
subdivided into complexes of either color, yielding a binomial term in the complex 
number. Thus, for example, the probability of having non-fluorescent cells (not (CFP OR 
YFP)) is given by 
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In the case of dual-colored complexes (pre-mixing), the total number of plasmids is 
binomial distributed between YFP and GFP, such that the probability of finding, for 
example, dichromatic cells (CFP AND YFP) is given by: 
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Similar expressions can be set up for all other cases. These can be algebraically simplified 
with the results given in Table SI.  
From these expressions, it is easy to compute the cotransfection ratio, 
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=µ .  [S8] 
Figure S1 is a representative result for the cotransfection ratio, r as a function of the 
transfection ratio, TR, for pre- and post-mixed complexes. Our model predicts that 
cotransfection is enhanced in pre-mixed complexes, and that the probability of 
cotransfection approaches 1 as TR approaches 100%. This is consistent with experimental 
results. The result shown in Figure S1 is particularly relevant in experiments, since one 
relies on cotransfection for the simultaneous delivery of two different plasmids. 
 
Distribution of Proteins 
The protein number distribution P(G) inherently carries the signature of the associated 
plasmid distribution P(X). Ignoring intrinsic and extrinsic noise in gene expression the 
mean number of proteins can simply be computed from the distribution of plasmids Eq. S4 
and the expression factor: 
qmkXkG µexpexp ==         [S9] 
The mean protein number G  can be obtained from single cell statistics. Additional 
relations are found between the parameters in Eq. S9 by evaluating how the percentage of 
non-fluorescent cells, p0 depends on them. p0 is identical to the percentage of cells with no 
activated plasmids in Eq. S4 or 1- TR, where TR is the transfection ratio. 
{ })1(exp)0(Prob:0 −=== −mqeXp µ .      [S10] 
Eliminating  µ from Eqs. S9 and S10, and with rearrangements, one finds 
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wa weae = .          [S11] 
where 
0exp ln
:
pk
G
a =  and amqw +=: . Solving Eq. S11 for w gives the Lambert W-
function. Hence, 
( ) aaeqmm aeff −== LambertW:        [S12] 
which only depends on measurable quantities and kexp. Fitting the expression factor as the 
only free parameter, µ and meff can be determined from single cell data. Consequently, the 
distribution of active plasmids is set by Eq. S4. The distribution of proteins then follows by 
stretching the distribution of plasmids according to Eq. 6. As argued in the main text, 
theory predicts discrete protein distributions, with peaks spaced by kexp. Of course, there 
are additional noise sources like all post-transfectional fluctuations and limited 
measurement accuracy. To compare theory with experiment, we replaced the peaks of the 
discrete protein distribution by Gaussians with the same area and a standard deviation of 
0.3 of each peak’s position to approximate extrinsic noise. Figure 5 shows the complex, 
plasmid and protein distributions for a set of single cell data obtained from this theory. A 
full list of parameters for all four data sets is given in Table SII. 
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Figure S1 (Schwake et al.) 
 
 
 
 
 
Figure S1. Theoretical prediction for the probability of cotransfection, r, as a function of 
the transfection ratio, t, in terms of percent cells transfected. The stochastic model of 
complex delivery predicts a strong discrepancy between pre-mixed and post-mixed (uni-
colored) complexes. The analytic solution is given in the supporting information. Shown 
are parametric plots with µ varying between 0 and infinity, while meff = 3.2 is held 
constant. 
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Table SI (Schwake et al.) 
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Table SI. Probabilities of finding non-fluorescent, monochromatic, and dichromatic cells 
for pre-mixing (hetero-complex) and post-mixing (homo-complex) cotransfection.  
 
 
 
 
Table SII (Schwake et al.) 
 
data p0 G  kexp meff µ *X  
Synchronized cells, Lipofectamine 0.70 1.55⋅106 1.3⋅106 3.21 0.37 4.0 
Asynchronous cells, Lipofectamine 0.70 8.72⋅105 0.8⋅106 2.89 0.38 3.6 
Synchronized cells, PEI 0.60 1.71⋅106 1.0⋅106 3.22 0.53 4.3 
Asynchronous cells, PEI 0.77 6.06⋅105 0.7⋅106 3.18 0.27 3.8 
 
Table SII. Parameters of the theoretical protein distribution as inferred from single cell 
data. The number of non-fluorescent cells, p0, and the mean number of proteins, G , have 
been determined experimentally. Fitting the expression factor kexp, to give optimal 
agreement between theory and experiment, the mean number of delivered plasmids, µ, and 
the mean number of activated plasmids per complex, meff = m⋅q, are set by theory. From 
these parameters, the plasmid distribution, P(X), is determined by Eq. S4. *X  is the 
mean number of expressing plasmids per fluorescent cell.  
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S2 Supplementary online information to Materials and Methods 
Materials. Earle’s MEM (Gibco, Catalog no. 41090-028), FBS (Invitrogen, Catalog no. 
10106-185), Leibovitz’s L-15 Medium (Gibco, Catalog no. 21083-027), 
LipofectamineTM2000 (Invitrogen, Catalog no. 11668-027) and OptiMEM (Gibco, Catalog 
no. 51985-026) were purchased from Invitrogen. 6-well culture plates (Falcon, Catalog 
no.353046) and thymidine (Catalog no. 6060-5) were purchased from VWR International 
GmbH. Linear PEI (25 kDa, Catalog no. 23966) was purchased from Polysciences, Europe 
GmbH, Eppelheim.  
All plasmids were obtained from BD Biosciences: the pEGFP-N1 plasmid (Catalog no. 
6085-1) consists of the transcriptional regulatory domain of cytomegalo virus (CMV) 
preceding the EGFP sequence; the pd2EGFP-N1 plasmid (Catalog no. 6009-1), derived 
from EGFP, contains a PEST amino acid sequence that targets the protein for degradation 
and results in rapid protein turnover; the pECFP-N1 plasmid (Catalog no. 6900-1) and the 
pEYFP-C1 plasmid (Catalog no. 6005-1), both derived from EGFP, encodes cyan and 
yellow fluorescent variants, respectively.  
BD Living Colors EGFP Calibration Beads (Catalog no. 632394) were purchased from BD 
Biosciences. Sterile PBS and HEPES buffered saline (HBS) were prepared in-house. 
Trypsin-EDTA (Catalog no. Z-26-M) was purchased from c.c.pro GmbH. 
 
Cell culture. A human bronchial epithelial cell line (BEAS-2B, ATCC) was grown in 
Earle’s MEM supplemented with 10% FBS at 37°C in a humidified atmosphere, 5% CO2 
level. Cells were maintained at 85% confluence. Transfection was performed on both non-
synchronized and synchronized cultures. A thymidine kinase double-block was performed 
to synchronize cells (Merrill 1998). Briefly, cells were cultured in synchronization medium 
(growth medium with 2mM thymidine) for 18 hours. Initial release was facilitated by an 
eight-hour incubation in regular growth medium. A second block was performed by 
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incubating cells in synchronization medium for another 17 hours, which was followed by a 
three-hour incubation in regular growth medium to allow mid-S-Phase transfection.  
 
Transfection optimization. Culture and transfection conditions were optimized at 
different levels. Different media on which the cells could grow were initially screened for 
autofluorescence and CO2 independence. Leibovitz’s L-15 Medium was found to be ideal 
for growing cells with minimal autofluorescence levels. Transfection was optimized by 
varying the LipofectamineTM2000:DNA and PEI:DNA ratios. Relative efficiencies were 
determined by Fluorolog Fluorescence Spectrofluorometer (Data not shown). Highest 
transfection efficiencies were obtained when 2µl of LipofectamineTM2000 or a 
Nitrogen:Phosphate ratio (N:P) = 8 of PEI:DNA was used with 1µg of DNA. EGFP 
expression stability was determined using time-course experiments; expression without 
photobleaching was found to be stable for at least four hours. 
 
Transfection. BEAS-2B cells were grown to 80% confluence from an initial seeding 
density of 1 x 105 cells/well in six-well plates at 37°C, 5% CO2 level 24 hours before 
transfection. Cells were washed and the medium is replaced with 1 ml OptiMEM/well 
immediately before transfection. Optimized transfection procedures were performed using 
either LipofectamineTM2000 or PEI; 1 µg of pEGFP-N1 or pd2EGFP-N1, corresponding to 
4⋅1011 plasmids, is used for transfecting each batch of cells. For Lipofectamine-mediated 
transfection, separate 100 µl preparations of 1% w/v pEGFP-N1/OptiMEM or pd2EGFP-
N1/OptiMEM and 2% v/v LipofectamineTM2000/OptiMEM were made at ambient 
temperature and allowed to stand for five minutes. The Lipofectamine transfection medium 
was prepared by adding the Lipofectamine solution to the plasmid solution. For PEI-
mediated transfection, separate 100µl preparations of 1% w/v pEGFP-N1/HBS or 
pd2EGFP-N1/HBS and PEI (N:P = 8)/HBS were made and the solutions were combined 
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by adding the PEI solution to the DNA solution. Transfection media were allowed to stand 
for an additional 20 minutes at ambient temperature to facilitate complex formation. Cells 
were incubated with 200 µl/well Lipofectamine or PEI transfection medium for 3 hours at 
37°C, 5% CO2 level. Negative controls were transfected with non-EGFP containing 
plasmids using the same delivery systems. After 3 hours of incubation the medium was 
removed, and cells were washed with PBS. Cells were reincubated with Leibovitz’s L-15 
Medium with 10% FBS prior to EGFP expression monitoring. 
 
Cotransfection. For the cotransfection experiments, we choose ECFP and EYFP plasmids 
on account of their similarities in terms of size (4731bp vs. 4733bp), promoter (early 
promoter of CMV), DNA replication origin (SV40) and translational efficiency (Kozak 
consensus translation initiation site). These plasmids only differ in the position of the 
MCS-site (C-terminal in ECFP, N-terminal in EYFP), apart from the fluorescence gene 
that they express, which are necessarily different to distinguish ECFP- from EYFP-
expressing cells. Cotransfection was performed with two kinds of preparations containing 
the same molar amount per plasmid. For one preparation, ECFP/Lipofectamine, 
EYFP/Lipofectamine, ECFP/PEI and EYFP/PEI were complexed separately. For the other, 
a mixture of ECFP and EYFP hetero-complexeswere complexed with Lipofectamine or 
PEI. Transfection using either the hetero-complexes (pre-mixed) or a mixture of homo-
complexes (post-mixed) were performed as previously described. Cells were reincubated 
in growth medium and CFP and YFP expression was monitored by fluorescence 
microscopy after 24 hours. 
 
Instrumentation. EGFP expression was monitored using a motorized inverted microscope 
(Axiovert100M, Zeiss) equipped with a temparature-controlled mounting frame for the 
microscope stage. SimplePCI (Compix) was used for all microscope controls. A mercury 
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light source (HB 100) was used for illumination, and a reflector slider with three different 
filter blocks was used for detection. EGFP and d2EGFP were detected with filter set 41024 
(Chroma Technology Corp., BP450-490, FT510, LP510-565), EYFP with F41-028 (AHF 
analysentechnik AG, BP500/20, FT515, BP535/30) and ECFP with F31-044 (AHF 
analysentechnik AG, BP436/20, FT455, BP480/40). An illumination shutter control was 
used to prevent bleaching. 
 
Data acquisition and quantitative image analysis. Images were taken at 10× 
magnification, with a constant exposure time of 1s, at 10 minute-intervals for at least 30 
hours post-transfection. Automated scanning and image capture for 25 view fields within a 
predefined 20mm diameter was programmed using the AIC module of SimplePCI. Briefly, 
the procedure captures individual brightfield images of the 25 view fields, then proceeds 
with a 30 hour loop where fluorescence images of each view field are taken at 10 minute 
intervals. At the end of the loop, brightfield images of the 25 view fields are taken again. 
Fluorescence images are consolidated into single image sequence files per view field. 
Negative control images were taken to assess lamp threshold values and autofluorescence, 
and were subtracted from corresponding image sequence files in SimplePCI to eliminate 
autofluorescence effects. To capture cell fluorescence over the entire sequence, regions of 
interest (ROIs) were manually defined around each cell in SimplePCI (Fig. 2). Changes in 
total gray measurements in individual ROIs were determined for each time point 
considered using a built-in function of SimplePCI.  
 
EGFP quantification. EGFP is a Phe64Leu/Ser65Thr mutant of the Auquorea victoria 
protein, GFP (Heim et al. 1995). It exhibits an intense emission spectrum, higher 
photostability, and a half life of > 24 hours in mammalian cells (Bi et al. 2002); (Cotlet et 
al. 2001); (Tsien 1998). The accurate determination of the total number of EGFP 
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molecules expressed in each cell is impeded by experimental limitations, notably bleaching 
and autofluorescence. We optimized culture, microscope and image acquisition settings to 
maximize the dynamic range while minimizing the effects of bleaching and 
autofluorescence. Our calibration procedure involved the use of an EGFP standard 
originally designed for flow cytometry. We used the microbead population coated with 
1.16⋅105 EGFP molecules. For each transfection experiment, 50µl Bead4 of the EGFP-
Calibration Kit was suspended in 1ml HBS in one well of a six-well plate. Fluorescence 
images of the beads were taken under the same conditions as the transfected cells. For each 
experiment, total gray values were obtained for at least 80 beads and an equal number of 
background regions adjacent to each bead. The average background corrected total gray 
value is obtained and used for converting intensity values to molecules of equivalent 
soluble fluorochrome (MESF) units. In our experiments, average calibration factors 
typically do not exceed a deviation of 11.2%. Calibrations between different assays have 
higher deviations due to illumination variations. Consequently, the calibration factor and 
the number of expressed EGFP molecules that we report are not absolute as a result of 
inherent and non-quantifiable differences in the quantum efficiencies of the EGFP 
chromophores inside the cells and the beads. However, relative intensity levels and the 
intensity distribution functions that are discussed in the paper are unaffected by the 
absolute calibration. 
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